The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic impact of percentage of squamous differentiation in patients with nonbilharzial squamous cell carcinoma and transitional cell carcinoma treated with radical cystectomy.
 
Marine Slim
No Relationships to Disclose
 
Eva Comperat
No Relationships to Disclose
 
Morgan Roupret
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; GlaxoSmithKline; Intuitive Surgical; Ipsen; Janssen-Cilag; Lilly; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Coloplast
 
Jerome Parra
No Relationships to Disclose
 
Jean-Marc Simon
No Relationships to Disclose
 
David Khayat
Stock and Other Ownership Interests - Agenus
Consulting or Advisory Role - Atlantic Sante; Celtic Biotech; Fleury Michon; genomic health; Scale Down
 
Marc-Olivier Bitker
No Relationships to Disclose
 
Jean-Philippe Spano
Consulting or Advisory Role - AstraZeneca; Lilly; MSD; Pfizer; Pfizer; Roche; Roche
Speakers' Bureau - Bristol-Myers Squibb; Gilead Sciences; Janssen; LEO Pharma; Novartis; Pfizer; Pfizer
 
Gabriel G. Malouf
Honoraria - GlaxoSmithKline; Janssen; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; Janssen; Novartis; Pfizer